Collaborate Disseminate
The U.S. Food and Drug Administration (FDA) has authorized a third COVID-19 vaccine dose for some immunocompromised individuals. The authorization comes after several weeks of speculation about future vaccine booster plans and the FDA stresses other va… Continue reading FDA authorizes third COVID-19 mRNA vaccine dose for immunocompromised
Over one third of Americans attempting to lose weight have at some point tried an over-the-counter weight-loss supplement. A new systematic review of over 300 clinical trials has found little to no evidence any of these supplements actually work, and t… Continue reading Little to no evidence weight-loss supplements work, large review finds
The US Food and Drug Administration’s controversial recent approval of Alzheimer’s drug Aduhelm has been subject to vociferous criticism from many in the scientific community. Amidst concerns surrounding the drug’s efficacy and price, several expert advisors to the FDA have resigned in protest and calls for top officials to step down are growing.
Category: Science
Tags: FDA, Alzheimer’s Disease, Drugs
Continue reading FDA Alzheimer’s call slammed as “Worst drug approval in recent US history”
A new Alzheimer’s disease treatment has been controversially approved for use in the United States despite an independent Food and Drug Administration (FDA) advisory panel reporting last year the drug’s Phase 3 trial results were inconclusive. The approval marks the first new treatment for Alzheimer’s in almost 20 years.
Category: Health & Wellbeing, Lifestyle
Tags: Alzheimer’s Disease, Dementia, FDA, Brain, New Atlas Audio
Continue reading First new Alzheimer’s drug in decades receives controversial FDA approval
The US Food and Drug Administration (FDA) has approved a new weight management drug called Wegovy (semaglutide). The drug was first approved as a type 2 diabetes treatment in 2017 and has subsequently been described as a “game-changer” for obese or ove… Continue reading FDA approves “game-changing” new weight loss drug
The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving… Continue reading First Phase 3 trial data for MDMA therapy sets path for approval
A striking new study testing a number of over-the-counter weight loss and sports supplements has found they contain many combinations of stimulants that have either previously been prohibited by the FDA or never approved for human consumption.Continue … Continue reading Experimental stimulants common in weight loss and sport supplements
A new study is raising questions over the safety of a commonly used food preservative found in hundreds of products. It’s suspected the compound, tert-butylhydroquinone (known as tBHQ or E319), impairs effective immune system activity and the researche… Continue reading Concerns raised over safety of common food preservative
The U.S. Food and Drug Administration (FDA) has approved a third COVID-19 vaccine for emergency use in the United States. Unlike the first two vaccines approved for use, this one is proven effective after only a single dose, and it can be safely distri… Continue reading First single-shot, “fridge stable” COVID-19 vaccine approved in US
New data submitted to the U.S. Food and Drug Administration from Pfizer claims its mRNA COVID-19 vaccine is stable for longer periods at warmer temperatures than previously thought. The new recommendations suggest the vaccine is stable for two weeks in… Continue reading Pfizer reduces ultra-cold requirements for its COVID-19 vaccine